Lewis A trisaccharide (Leᵃ) – unlocking the cell identification “password” for precision medicine

Lewis A trisaccharide is a crucial carbohydrate epitope on the surface of human cells and a star molecule at the intersection of glycobiology and immunology. It is not only a key messenger for cell-to-cell recognition and communication, but also shows great application potential in disease diagnosis, targeted therapy and drug development, and is a precious bridge connecting basic research and clinical translation.

Chemical Information

Chemical name: Lewis A trisaccharide (detailed IUPAC name can be provided upon request)

Common name: Lewis A trisaccharide, Leᵃ antigen

Chemical formula: C20H35NO15

Molecular weight: 529.49 g/mol

CAS number: 56570-03-7

Structural features

The exquisite and unique structure of Lewis A trisaccharide is the molecular basis of its biological functions:

Characteristic trisaccharide skeleton: It is composed of fucose, galactose and N-acetylglucosamine linked by specific α-1,4 and β-1,3 glycosidic bonds, forming a “fingerprint” structure that is specifically recognized by antibodies and lectins.

Terminal immunodominant structure: Fucose is connected to N-acetylglucosamine with α-1,4 bonds, forming the immunodominant epitope of the Leᵃ antigen, which is the core of its high-precision recognition by specific antibodies (such as anti-Leᵃ monoclonal antibodies).

Spatial conformation specificity: Its three-dimensional spatial folding conformation provides a highly specific binding interface for protein recognition, ensuring the accuracy of biological interactions.

Main applications and advantages

1. Key biomarkers for cancer diagnosis and prognosis assessment

High-efficiency serum detection: Leᵃ antigen is the core epitope of the famous tumor marker CA19-9. Lewis A trisaccharide is the gold standard raw material for the development of highly sensitive and specific CA19-9 immunoassay kits. It is widely used in the auxiliary diagnosis, efficacy monitoring and recurrence warning of pancreatic cancer, colorectal cancer, cholangiocarcinoma, etc.

Histopathological staining: It can be used as a standard or probe to optimize immunohistochemical staining of Leᵃ antigen expression in tissue sections, providing an accurate basis for pathological diagnosis.

2. Development tools for targeted drugs and innovative therapies

Drug delivery system: Taking advantage of the overexpression of Leᵃ antigen on the surface of specific cancer cells (such as gastrointestinal tumors), Lewis A trisaccharide can be used as a target to couple to nanomedicines, liposomes or antibody drug conjugates to construct a "precision-guided" drug delivery system, which can significantly improve efficacy and reduce systemic toxicity.

Vaccine development: Cancer vaccines based on tumor-associated carbohydrate antigens are a cutting-edge research direction. Highly pure Lewis A trisaccharide can be used as a key antigen to develop therapeutic vaccines against Leᵃ-positive tumors and stimulate the body's specific immune response.

3. Basic research and analysis of interaction mechanisms

Host-microbe interaction research: Many pathogenic bacteria (such as Helicobacter pylori) and viruses specifically recognize blood group antigens such as Lewis A on the surface of host cells through adhesins on their surfaces to achieve colonization and infection. Lewis A is an ideal molecular tool to study this critical process.

Glycobiology and Immunology Research: As part of important cell surface glycoconjugates, Lewis A trisaccharides play important roles in cellular adhesion, signal transduction, and immune regulation. It is the cornerstone for exploring these complex biological mechanisms.

Conclusion

Lewis A trisaccharide is not just an oligosaccharide molecule, it is a precise key to deciphering cell surface information and opening the door to targeted therapy. From highly sensitive in vitro diagnostics to cutting-edge targeted anti-cancer drugs, its application prospects in the fields of life sciences and medicine are extremely broad.